Relapsed/Refractory Acute Myeloid Leukemia (AML)
14 clinical trials · Condition
◉ Watch Relapsed/Refractory Acute Myeloid Leukemia (AML)
| Record | Firm | Date |
|---|---|---|
| CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) (NCT05143996) | Cullinan Therapeutics Inc. | 2021-11-18 |
| Safety, Tolerability, PK, PD, and Efficacy of AMG 427 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia (NCT03541369) | Amgen | 2018-09-14 |
| CAR-T Cells Therapy in Relapsed/Refractory Acute Myeloid Leukemia (NCT03473457) | Zhujiang Hospital | 2018-04-01 |
| Pilot Study of Crenolanib Combined With Standard Salvage Chemotherapy in Subjects With R/R AML (NCT02626338) | Arog Pharmaceuticals, Inc. | 2016-02-01 |
Track Relapsed/Refractory Acute Myeloid Leukemia (AML) automatically
Every clearance here is in the API, with alerts when new ones post.